Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Events

08 Dec 2026 - 10 Dec 2026
25 Jan 2027 - 28 Jan 2027

Implantable Ultrasound Device Enhances Local Drug Delivery in Glioblastoma

By HospiMedica International staff writers
Posted on 27 Oct 2026

Glioblastoma is an aggressive brain tumor that frequently recurs after surgery. More...

Although surgeons can remove visible tumor tissue, residual cancer cells may remain in surrounding brain tissue and contribute to recurrence. This creates a need for local treatments that can reach these remaining cells while limiting systemic exposure. To address this challenge, researchers have developed an implantable ultrasound-enhanced drug-delivery device.

The Massachusetts Institute of Technology (MIT) has developed the Long-term Ultrasound-enhanced Convective Injection Device, or LUCID, a flexible implant designed for placement during brain surgery. As thin as a sheet of cardstock, the device combines a drug reservoir for extended release with ultrasound transducers that use sound waves to improve drug distribution through surrounding brain tissue.

LUCID integrates a 3D-printed drug-delivery cannula with an array of 24 miniature ultrasound transducers positioned near the needle tip. The transducers generate ultrasound waves that help released molecules diffuse farther into nearby tissue. The device holds about 100 microliters of fluid, uses a passive osmotic pump for infusion, and can be controlled wirelessly through Bluetooth. Its small battery can also be recharged wirelessly.

The researchers first evaluated the system in tissue phantoms, gel-like materials designed to mimic human tissue. In these tests, ultrasound-enhanced delivery spread drug molecules farther than delivery without ultrasound. The team then tested the device in mice using an MRI contrast agent and found that the agent spread farther through the brain.

If developed for patient use, the drug cannula and ultrasound array would be placed inside the skull. The battery and other electronics could remain outside the skull. The technology may also be applicable to small-molecule drugs, immunotherapies, nucleic acids including gene therapies, and delivery in organs beyond the brain. The work was published in Device on October 26, 2026.

“We have 24 transducers in one ultrasound array, which can help a given drug bypass the blood-brain barrier and enhance the drug infusion. The device also gives doctors options in terms of the size, the length and the number of infusions,” said Canan Dagdeviren, an associate professor of media arts and sciences at MIT and the senior author of the study.

“We started with the brain as a follow-up to our ImPULS technology, but eventually this can be used for other soft tissue treatments for different types of drugs, different types of interventions in deep body tissue. We are showing that we can make any kind of payload be distributed in a better way,” Dagdeviren added.

Related Links
MIT


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Syringe Pump
SP50 Series
Hypodermic Syringe
SurTract™ Safety Syringe
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Design-science framework integrating CML and LLM pipelines for supply chain risk evaluation. (Gupta I, Konduru H, Correa S, et al. A causal analytics approach for interpretable supply chain risk and supplier performance evaluation. Supply Chain Analytics, 2026. doi:10.1016/j.sca.2026.100248)

Causal AI Tool Withholds Ovarian Cancer Treatment Recommendations When Evidence Insufficient

Ovarian cancer treatment often requires individualized decisions, particularly when available patient data do not clearly favor one therapeutic approach. However, artificial intelligence (AI) systems may... Read more

Patient Care

view channel
Image: A view inside the custom virtual reality environment used in the study: a calm room with a teddy bear, soft colors and large windows looking out over the sea. (Image Credit: Walaa S. Abu Rukbah et al., Virginia Commonwealth University; CC-BY 4.0, https://creativecommons.org/licenses/by/4.0/)

Virtual Reality Program May Reduce Anxiety Before Pediatric Surgery

Presurgery anxiety affects an estimated 50% to 75% of children undergoing surgery and can complicate anesthesia induction, increase postoperative pain, and prolong recovery. Sedation is often used to manage... Read more

Medical Imaging

view channel
Image: Overview of the study design, including participant recruitment, multimodal neuroimaging analysis, stage- and cognition-informed feature selection, and development and validation of the DBFG-Net model. CKD-CI, CKD with cognitive impairment; CKD-NCI, CKD without cognitive impairment; HCs, healthy controls; CBF, cerebral blood flow; DBFG-Net, Dual-Branch Feature-Gated Network. (Photo courtesy of Wenbo Yang and Lijun Song, Capital Medical University)

AI Combines Brain Imaging Features to Identify Cognitive Impairment in CKD

Chronic kidney disease (CKD) can affect multiple organs, including the brain, with cognitive impairment emerging as a common complication. Changes in executive function, attention, and memory can reduce... Read more

Health IT

view channel
Image Credit: Shutterstock

Telemonitoring Program Improves Quality of Life After Heart Failure Discharge

Heart failure is a chronic condition associated with high mortality, frequent hospitalizations, and reduced quality of life. Patients face particularly high risks of readmission and death after discharge,... Read more

Point of Care

view channel
Image: Jessica Ramella-Roman, professor of biomedical engineering at Florida International University, holding the PPRIM (Portable Preterm Imaging) device designed to detect early signs of preterm labor risk. (Photo courtesy of Florida International University)

Handheld Imaging Device May Help Identify Preterm Birth Risk Earlier

Preterm birth, defined as delivery before 37 weeks of pregnancy, can lead to serious neonatal complications, including neurological, developmental, and respiratory problems. However, identifying pregnancies... Read more

Business

view channel
Image: Stryker has acquired ZuriMED, adding the FiberLocker System, a rotator cuff augmentation technology designed to strengthen repairs, to its Sports Medicine portfolio. (Photo courtesy of ZuriMED)

Stryker Completes Acquisition to Broaden Shoulder Surgery Offerings

Stryker (Portage, MI, USA) has completed its acquisition of ZuriMED (Zurich, Switzerland), a privately held developer of the FiberLocker System, expanding its Sports Medicine portfolio with a commercialized... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.